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microRNAs (miRNAs) are small non-coding RNA which play an important role in gene 
regulation. Majority of miRNAs are encapsulated in exosomes thereby confer protection 
against degradation and transport across cell. Recent study suggests that 1) humans 
absorb microRNAs from cow’s milk, 2) milk microRNAs are delivered to peripheral 
tissues where they alter the expression of human genes, and 3) endogenous synthesis of 
microRNAs does not compensate for dietary microRNA depletion in mice. Studies 
suggest that cow’s milk exosomes can be transported across the intestinal mucosa by 
processes involving endocytosis and exocytosis. Here we tested the hypothesis that 
endothelial cells also transport milk exosomes. Using FM-labelled exosomes, the 
transport of exosomes in HUVECs can be assessed, i.e., the quantitatively most important 
fraction of exosomes in milk taken up by HUVECs. Exosome uptake followed Michaelis-
Menten kinetics (Vmax = 0.057±0.004 ng exosome protein x 40,000 cells
-1 x hour-1; Km= 
17.97±3.84 µg protein/200 µl media) and decreased by 80% when the incubation 
temperature was lowered from 37°C to 4°C, consistent with carrier-mediated transport. 
When exosome surface proteins were removed by treatment with proteinase K or 
transport measured in the presence of carbohydrate competitors, transport rates decreased 
by 30% to 50% compared with controls, consistent with a role of surface glycoproteins in 
 
 
endothelial transport. Treatment with cytochalasin D caused a 50% decrease in transport, 
consistent with endocytosis. We conclude that human endothelial cells transport bovine 
exosomes by endocytosis and propose that this is an important step in the delivery of 
exosome cargo to peripheral tissues. 
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Extracellular Vesicles (EVs)  
Extracellular vesicles (EVs) are term used to describe the diverse types of plasma 
membrane or endosomal vesicle origin (1). They appears in spherical form and composed 
by phospholipids and specific proteins which separates them from plasma membrane 
origin with size ranging from 30 nm to 1 µm (2-4). They are secreted by both eukaryotic 
and prokaryotic cell into the environment for cell-to-cell communication, protection, and 
exchange of genetic information (5).   
In the beginning, EVs were considered as cellular debris, which is resulted from 
the membrane remodeling of apoptotic cells (6). Indeed, the first and well-known EVs 
was apoptotic bodies which is released during apoptosis. However, healthy cells also 
release vesicles which comprised by large and small vesicles (7-10). Some EVs are 
derived from the shedding of plasma membrane which latter known as shedding vesicles 
or microvesicles (11), whereas other EVs are derived from the exocytosis process of 
multivesicular bodies (MVB) which known as exosome (12). These two types of EVs are 
majorly found to be released by the cell into the plasma as well in other biological fluids 
such as semen, saliva, urine, breast milk, cerebrospinal fluids, bronchoalveolar and 
lavage fluid, amniotic fluid, and malignant ascites (13-18).   
Perhaps the first experiment regarding the presence of EVs was dated back in 
1967 when Wolf (19) reported phospholipids rich small vesicle ranging from 20 to 50 nm 
from the platelet termed “platelet dust” that contains the platelet factor 3 for blood 
coagulation. Ultracentrifugation removed the small vesicle and caused a prolonged blood 
coagulation. The presence of small vesicles were confirmed later in fetal bovine serum, 
nerve tissue, healthy cell and cancerous cell with unknown biological function (7-9). In 
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the early 1980s, two independent researchers have identified the function of this small 
vesicle for transporting transferrin and its receptor during reticulocyte maturation (10, 
20). Further electron microscopy identified that the small vesicle was formed by inward 
budding of plasma membrane into intracellular endosomes followed by exocytosis of late 
endosome or multivesicular endosomes (MVBs) (10, 21). Term “exosomes” than had 
been used to characterize this small vesicles produced by mature reticulocytes which 
carry the transferrin receptor without the presence of cytosolic enzyme that can be 
isolated using centrifugation technique (12, 22). Noted that the term exosome used here 
should be distinguished from the RNA degrading complex in the cytosol (23). 
However, these findings were not appreciated enough until Raposo et al. (24) 
reporting the presence of major histocompatibility complex (MHC) class II in exosome-
like vesicle produced by antigen presenting cell. This result indicated that exosome is not 
only produced by the reticulocytes, but also from other cells such as B cell. This finding 
was confirmed by several studies that cancer and other normal cells also produce 
exosome vesicle that carry functional enzyme (25), mRNA (26) and microRNA (27, 28). 
Since then, large body of articles have identified numerous EVs isolated from different 
cell with distinct functional therapies such as cardioprotection (29), drug delivery (30), 
stroke therapy (31), and gene therapy (32).     
  
4 
 
Classification of Cell Derived EVs  
Although several cell derived EVs have been well characterized in numerous 
studies, however there is no consensus regarding the nomenclature and characteristic of 
cell derived EVs (33, 34). This condition led to the confusion on determining the cell 
derived EVs. For instance, one can use the term “ectosomes” (35, 36), “exosome-like 
vesicles” (37, 38), “argosomes” (39), “tolerasomes” (40, 41), “prostasomes” (42), 
“cardiosomes” (43) or “vexosomes” (44) to explain small vesicle with size <100 nm. The 
term of microparticles and microvesicles have been used collectively by numerous 
authors to describe direct, vesicular form of membrane shed vesicles with size >100 nm 
(45). Moreover, exosomes can be defined in different ways, i.e., the exfoliated plasma 
membrane, which has the plasma ecto-enzyme activity (9), or the vesicles that formed by 
inward budding of limited plasma membrane into endosome to form MVBs followed by 
exocytosis process of MVBs after fusion with plasma membrane (22). In order to make 
the classification clear, the term microvesicles (MVs) will be used instead of 
microparticle to explain vesicle larger than 100 nm.     
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Table 1.1. Characteristics of different types of cell derived EVs*)  
Feature Exosome Microvesicles Membrane 
Particles 
Ectosomes Exosome-like 
particle 
Apopto-
tic bodies 
Size (nm) 30-100 100-1,000 50-80 50-200 20-200 50-5000 
Density 
(g/ml) 
1.13-1.19 ND 1.03-1.07 ND 1.12-1.18 1.16-1.28 
Mechanism 
of 
generation 
Exocy-
tosis of 
MVBs 
Budding/blebbing 
of plasma 
membrane 
Budding/ 
blebbing of 
plasma 
membrane 
Budding/ 
blebbing of 
plasma 
membrane 
ND Release 
from 
dying/ap
optotic 
cells 
Morphology Cup-
shaped 
Irregular shape Round  Bilaminar 
round 
Cup-shaped Heteroge
neous 
Origin Endoso-
mes 
Plasma membrane Plasma 
membrane 
Plasma 
membrane 
Internal 
compartment
? 
ND 
Protein 
markers 
Tetra-
spanin 
(CD63, 
CD9, 
CD81), 
LAMP, 
Alix, 
TSG101 
Annexin V, 
integrins, 
selectins, CD40 
ligands 
CD133 CD59, 
CR1-
related 
enzyme 
TNFRI Histone 
*) Adapted from (13, 35, 45-50). ND, not defined.   
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Based on literature, there are several categories of cell derived EVs. Some 
classified cell derived EVs into two classes (51), three classes (1, 45, 47, 49), four classes 
(48) or more (46). Characteristics of cell derived EVs are reviewed in Table 1.1. These 
discrepancies in classification of cell derived EVs are caused by many factors, i.e., 
isolation procedure, size, density, morphology, lipid and protein composition as well 
cellular origin (33, 48). Thus, to mediate the ambiguous term in cell derived EVs 
research, International Society of Extracellular Vesicles (ISEV) has proposed some 
criteria to represent the minimal characterization of EVs. These including: 1) the 
presence or absence of some protein marker, which can be detected by western blot, flow 
cytometry, or mass-spectrophotometry, 2) characterization of single vesicles should be 
performed by using electron microscopy in wide area accompanied by size distribution 
measurement, 3) presence of controls in the studies of the functional activity of EVs (34).   
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Exosome  
Exosome is small, nano-sized vesicle with diameter of 30-100 nm and density of 
1.13-1.19 g/mL (50). It is secreted by normal or cancerous cell in spontaneous or 
inducible processes (9, 52, 53). It is present in biological fluid such as plasma, saliva, 
urine, breast milk, bronchoalveolar lavage fluid, amniotic fluid, cerebrospinal fluid, and 
malignant ascites (13, 14, 17, 54).  
Exosome term was first determined by Trams et al (9) as a vesicle derived from 
the plasma membrane although the term was started to change two years afterwards when 
two independent researchers, Harding et al (10) and Pan et al (20), discovered a small 
vesicle formed from inward budding of late endosomes. This small vesicle contains 
transferrin receptor, which add another route for transferrin receptor recycle during 
maturation of red blood cells (12). Electron microscopy further revealed the formation of 
intraluminal vesicles (ILV) formed by invagination or budding from limited membrane of 
endosome, which will fuse with plasma membrane to release small vesicle through 
exocytosis process (10, 21). Small vesicles, which are released from MVBs, were later 
termed “exosome” (22) and later were confirmed in B-cell by Raposo et al (24). Since 
then, term exosomes is used to describe the small vesicles formed by the inward budding 
of endosomes (Figure 1).   
Exosomes harbor protein, lipid, carbohydrate and nucleic acids such as miRNA, 
small non-coding RNA and mRNA which derived from their cellular origin (55). These 
components, particularly miRNA, reflect the functionality to the host cell and posse 
molecular signature from their cellular origin (38, 47, 56-58). Therefore, it was thought 
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that molecular characterization of exosome exert potential biomarker of the disease such 
as cancer.    
The protein content in exosome comprised by protein involved in MVBs 
generation such as membrane transport and fusion protein (e.g., Rab, annexins, flotillins), 
MVB biogenesis (e.g., ESCRT family: Alix, TSG101), cytoskeletal protein (e.g., actin, 
tubulin, syntenin, and moesin) and tetraspanin (e.g., CD63, CD9, CD81, CD82) although 
other proteins which is not related to the MVBs generation also present in exosome such 
as metabolic enzymes, heat shock protein, ubiquitin, and protein important for signal 
transduction, apoptosis and protein synthesis (46, 59, 60). Protein contents in exosomes 
are reviewed in Table 1.2.  
The lipids of exosome comprised by cholesterol, phospholipids, sphingolipids, 
ceramides and lipid raft molecule (1, 46, 47). The carbohydrates in exosome is enriched 
in mannose, polylactosamine, α-2,6 sialic acid and complex N-glycans, which is 
important for protein recruitment in exosome (61-63). All of these components discrete 
exosomes from other organelle or plasma membrane (47). Currently, all of the protein 
and lipid components of exosomes are available online from three databases; EVpedia, 
Exocarta and Vesiclepedia (64, 65).    
Exosome also carry nucleic acids which can be translated into functional protein 
or regulate the activity of gene (26, 66, 67). Several RNA families such as messenger 
RNA (mRNA), microRNA (miRNA), transfer RNA (tRNA), ribosomal RNA (rRNA), 
piwi RNA (piRNAs), mitochondrial RNA (mitRNA) and long non-coding RNA present 
in exosome (60, 68-70). The presence of nucleic acids, especially the miRNA, are 
thought to be a reliable marker for exosome due to the equal level of miRNA in exosome 
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compared with the parental cell (15, 70, 71). However, identification of miRNA in 
exosome is challenged due to the low level of miRNAs in exosome compared to their cell 
origin (72). In addition, recent studies also suggest that other proteins; e.g., the HDL and 
argonaute, also transport miRNA which limit the potential use of miRNA detection as a 
marker of exosome (73-75).      
Based on the first discovery of exosomes, the exocytosis process of MVBs is the 
general process of exosomes biogenesis. The engulfment of plasma membrane by clathrin 
or non-clathrin coated pits resulting in early endosome was the first pathway in exosome 
biogenesis. The formation of early endosome was followed by multivesicular bodies 
(MVBs) development through trans-golgi network protein interaction, i.e., endosome 
sorting complex required for transport (ESCRT), resulting in the formation of 
intraluminal vesicle (ILV). The ESCRT protein family is also important for the fate of 
MVBs (76). The fusion of MVBs with the plasma membrane resulted in the releasing of 
exosomes. This mechanism is first confirmed in red blood cell, which was also 
established in dendritic cells (77).           
However, there are other exosome biogenesis pathways, which are ESCRT-
independent process. This pathway rises as silencing the production and activity of 
TSG101 or ESCRT complex did not hamper the production of exosome in some type of 
cells (53, 78, 79). For instance, silencing the production of CD69 protein in melanocyte 
has caused significant reduction in exosome biogenesis (80) while inhibiting ceramide 
production in oligodendroglial cell has resulted in lower production of exosomes (81). 
These results indicated the ESCRT-independent pathway for exosome biogenesis as well 
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the cellular specific pathway for exosome biogenesis, which may explain the variety on 
molecular signature in exosomes (82).   
Upon releasing into the plasma or serum, recent direct and indirect evidence 
reported that exosomes are taken up by the cell through several proposed mechanisms in 
order to transfer the cargo into recipient cells. Studies showed that exosomes uptake is 
endocytosis-dependent process as indicated by fluorescence microscopy method (83-88). 
In addition, other types of endocytosis process, i.e., phagocytosis and micropinocytosis, 
have been reported (89, 90). However, exosomes are also transported by direct fusion 
with plasma membrane of the cell, which suggesting the endocytosis-independent 
pathway for cellular internalization of exosomes (91).  
 
Microvesicles  
Microvesicles, also known as shedding vesicles, microparticles, ectosomes or 
membrane particles, is vesicles produced by outward budding and fission of plasma 
membrane (51, 92). They are found in most of biological fluids as well in atherosclerotic 
plaque (93, 94). Unlike exosomes, this small vesicles has heterogeneous shape, larger in 
diameter (from 100 nm up to 1 µm) and float in sucrose gradient with density of 1.032-
1.07 g/mL, slightly lower than exosomes (46, 48, 92).  
Microvesicles were first characterized by Wolf (19) as “platelet dust” that contain 
platelet factor 3 for blood coagulation. The vesicles were comprised by phospholipid rich 
vesicles and secreted by most type of cells in the body including circulating cells, 
vascular cells, and cardiomyocytes (95). Stress, hypoxia, apoptosis, inflammation, 
complement attack, bacteria lipopolysaccharides (LPS), intercellular calcium elevation, 
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senescence and platelets activation have been reported to stimulate the release of 
microvesicles (96-102). Thus, microvesicles play important role in coagulation (103), 
atherosclerosis development (104), tumor invasion and metastases (94), immunity and 
inflammatory modulator (105-107).    
Due to the plasma membrane origin, microvesicles contain several proteins and 
lipid from plasma membrane origin. In addition, microvesicles also acquired some 
protein from plasma or endocytic compartment, which indicated sorting protein process 
in microvesicles (99, 110). Although, they are originated from plasma membrane of the 
cells, protein and lipid component of microvesicles, as well the cargo content of 
microvesicles, are depend on several factors; i.e., cellular origin, cellular stage (e.g., 
resting, stimulated), and the stimulation agent (111). For instance, stimulation of platelet 
with complement complex C5b-9 resulted in platelet-derived microvesicles enriched in 
C9 neoantigen of the C5b-9 complex and α-granule-derived-coagulation factor V (or Va) 
(112). In addition, stimulation with this agent produced platelet-derived microvesicles 
that did not bind with fibrinogen (113).  
Although it is cleared that microvesicles was originated from plasma membrane 
of the cells, formation and released of microvesicles from plasma membrane is poorly 
understood. It is hypothesized that activated cells will cause an elevation of calcium level 
in the cytosol, particularly in site of vesiculation, will cause activation of kinases and 
calpain as well inhibition of phosphatases, which in turn will break the membrane 
cytoskeleton, releasing microparticles to extracellular compartment of the cells (98). Prior 
to membrane breakdown, it is hypothesized that non-secretory exocytic vesicles will 
accumulate into the plasma membrane, causing the budding of plasma membrane (51). 
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This event is characterized by the presence of desmoyokin and annexin 2, a marker of 
exocytic organelle, in microvesicles (111). It is also reported that budding of 
microvesicles from plasma membrane requires two important proteins: endosomal sorting 
complex required for transport (ESCRT) and arrestin domain-containing protein 1-
mediated microvesicles (ARMMs) (114, 115). Inhibition of ARMMs along with ESCRT 
inhibits the release of microvesicles from plasma membrane, which indicated the main 
function of these two proteins in mediating the release of microvesicles from plasma 
membrane (116).  
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Figure 1.1. Formation of exosome from multivesicular endosome. A limited plasma 
membrane is engulfed into the early endosome where it will mature into multivesicular 
endosome with the formation of intraluminal vesicle (ILV) derived from late endosome. 
The multivesicular endosome then fused with the plasma membrane to release small 
vesicle containing transferrin receptor. Adapted from Thery et al (46).   
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Table 1.2. Protein and glycolipid content of exosomes*)  
Protein Function/Class Protein 
Antigen presentation MHC Class I/II, CD86 
Adhesion molecules/targeting   Milk Fat Globule-Epidermal growth factor VIII 
(MFG-E8 or lactadherin), integrin (α3, α4, αM, 
αL, β1, β2), tetraspanin (CD63, CD9. CD37, 
CD53, CD81, CD82)  
Membrane transport and fusion  RAP1B/RABGDI, Rab 7, Rab 2, Annexins 
(Annexins 1-7), dynamin, syntaxin, AP-1, 
Arp2/3, SNAP 
Heat-shock protein HSC70, HSP84/90  
Cytoskeletal protein  Actin, cofilin, tubulin, moesin, rodixin, advilin, 
vimentin, talin, CAP1, ezrin 
Raft-associated protein or glycolipids Flotillin, CD55, CD59, GM1, GM3, Gi2α, 
cholesterol, stomatin 
Enzymes  Pyruvate kinase, alpha enolase, ATPase, glucose 
6-phosphate, isomerase, peroxiredoxin 1, 
aspartate amino transferase (ASAT), fatty acid 
synthetase, ATP citrate lyase    
MVB formation Alix, TSG101, Gag 
Signal transduction  Erk2, Fyn, RhoA/C, catenin, syntenin  
*) Adapted from (108) and (109)  
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Upon the release into extracellular compartment, microvesicles are taken up by 
the cells with half-life around 10 minutes in the plasma (117). Study indicated that 
microvesicles are taken up by the cells through endocytosis and phagocytosis pathway 
upon binding with specific receptor in the cells (118). Developmental endothelial locus 
(Del)-1 is important protein that recognize the phosphatidylserine in microvesicles and 
mediates the endocytosis process of microvesicles through binding with integrin, αvβ3, 
on cells (119). The lactadherin, also known as milk fat globule-epidermal growth factor 
8, is mediated the phagocytosis process of microvesicles upon binding with integrin of 
macrophages (120). In addition, other proteins are reported to mediate the uptake of 
microvesicles; growth arrest specific 6 (GAS6), β2-Glycoprotein I, P-selectin (117).                          
           
Apoptotic Bodies  
Apoptosis, also known as programmed cell death, is a major mechanism of cell 
death, both in cancer and normal cell, indicated by the release of membrane vesicles 
called apoptotic bodies or apoptosomes (6). The apoptosis process begins by activation of 
caspase protein in response to ligation of the death receptor in the cell membrane 
(CD95/FAS, TNFR1, TRAILR) (121). Activated caspase will cleave certain regions of 
genomic DNA, forming oligonucleosome ladder, followed by migration of 
oligonucleosome into the cytosol due to increased permeability of nuclear pores (122, 
123). Upon exiting the nucleus, the oligonucleosome will migrate into plasma membrane, 
forming “blebs” at the plasma membrane (124, 125). It is reported that rho effector 
protein I (ROCK I) is cleaved by caspase and promote the formation of apoptotic blebs 
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during apoptosis (126, 127). The blebs will contain cellular organelle, which will be 
cleared through phagocytosis by macrophage (128).  
 Although apoptotic bodies can be distinguished from others EVs; e.g., exosomes 
and microvesicles, by size (500-4000 nm in diameter), study suggests the presence of 
cellular organelle in small vesicles with diameter of 50-500 nm, which indicating the 
apoptotic bodies (129). In addition, some proteins present in other EVs such as epithelial 
cell adhesion molecules (EpCAM), CD63, CD81, which is found in most of extracellular 
vesicles including apoptotic bodies, and annexin V, which is detected in microvesicles 
and apoptotic bodies (130, 131). The similarity in size and protein composition between 
apoptotic bodies and others EVs have added the difficulties in characterizing EVs from 
the sample. Moreover, there is no established protocols for isolating apoptotic bodies. 
One method that has been developed to distinguish apoptotic bodies from other EVs is 
RNA analysis. Based on this technique, apoptotic bodies majorly composed by ribosomal 
RNA, which is lacked in others EVs such as exosome and microvesicles (131).  
Similar with other EVs, apoptotic bodies are cleared or taken up by the cells to 
mediate transfer of genetic between cells. Phagocytosis by the macrophage is the major 
route for apoptotic bodies’ clearance during normal development (132). The clearance 
process of apoptotic bodies consisted of 4 distinct steps: accumulation of phagocytes at 
the site where apoptotic cells are located through “find me” signals, recognition of 
apoptotic bodies through “eat me” signals and their cognate receptors, engulfment by 
macrophages through signaling pathways that regulate the cytoskeletal rearrangement of 
macrophage, digestion of engulfed apoptotic bodies within macrophage (133, 134). The 
presence of thrombospondin, complement protein C3b, and annexin V in apoptotic 
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bodies are believed to guide the macrophage to eat the apoptotic bodies, which serve as a 
protein marker for apoptotic bodies (125, 132, 133). Internalization of apoptotic bodies 
into targeted cells has been reported to promote several functions such as anti-
inflammatory properties (135, 136), viral transfer (137), endothelial cell repair (130), as 
well as cancer metastases (138).     
               
Biological Function of Cell derived EVs  
The presence of nucleic acids such as DNA, RNA, miRNA as well long non 
coding RNA in EVs has risen the importance of EVs for cell-to-cell communication 
(139). Indeed, the nucleic acid, particularly RNA, in EVs can be translated by recipient 
cells to promote function such as transcription termination (140) and lipid synthesis 
(141). Moreover, it is reported that most of detectable microRNA present in biological 
fluid such as serum, saliva and breast milk is encapsulated in EVs, particularly in 
exosomes (27). EVs exert potential protection against harsh environment and enzymatic 
degradation (142), which contribute to the transport and genetic transfer into recipient 
cells through local or systemic circulation in endocrine-like pathway (82).   
Study suggest that mRNA and microRNA-containing EVs can be transmitted 
across species. Using mouse dendritic cells, Valadi et al (26) have successfully 
demonstrated that mRNA from mouse dendritic cells can be translated into functional 
protein in human mast cells. In addition, Sun et al (143) reported the immune-related 
miRNAs from cow’s milk can influence gene transcription in human macrophage cells 
resulting in macrophage differentiation. Recent study conducted by our lab (67, 144) also 
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supported the notion that microRNAs present in cow’s milk and egg EVs can be exported 
into human blood and affect gene expression in human body.  
In addition, protein, enzyme and lipid components in EVs have been proposed to 
mediate several physiological or biochemical process in the body, i.e., cellular 
development, differentiation, and immune function. For instance, exosomes account for 
transferrin receptor transport from reticulocytes into the blood during red blood cells 
maturation (10, 145). In addition, Skokos et al (146) demonstrated that exosomes 
released from mast cells are able to induce maturation of immature dendritic cells (DC) 
by its ability in antigen presentation to T cells. Further studies indicated that the ability of 
antigen presenting of DC to T cells is mediated by exosomes released from mature DC 
(147, 148).    
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MicroRNA (miRNA)  
microRNA (miRNAs) is small, ~21 nucleotides long, non-coding RNA that plays 
an important role in gene regulation, both in animals and plants, by binding to 
untranslated region of mRNA, resulting in translation inhibition or mRNA degradation 
(149). It was first discovered in C. elegans as a non-coding RNA, produced by lin-4 and 
let-7 genes, that binds to 3-untranslated region of lin-14, lin-28, lin-41, lin-42 and daf-12 
mRNA (150, 151). Since then, let-7 RNA homolog has been identified in a wide range of 
animal species, e.g., vertebrae, ascidian, hemichordate, mollusk, annelid, and arthropod 
(152). This small, single stranded RNA was named miRNA and regulates as much as 
60% of mammalian genes (153-156).   
Since the discovery of miRNAs, other small RNAs have been characterized in 
animals, plants, and fungi, which including small interfering RNAs (siRNAs) and Piwi-
interacting RNAs (piRNAs) (157, 158). They have distinct characteristic, although have 
similarities particularly in post-transcriptional modification. The characteristic between 
miRNA, siRNA and piRNA are reviewed in Table 1.3.  
             
MicroRNA Biogenesis, Maturation and Molecular Mechanism   
Study suggest that miRNAs are encoded in the nucleus. Most of the miRNAs in 
human, around two third, are encoded in the intron region of protein-coding genes as well 
in long non-coding transcript (159). This condition let to the assumption that miRNAs are 
transcribed along with the host genes using RNA polymerase II (160, 161). However, 
Bortolin-Cavaille et al (162), reported the introgenic independent pathway of protein 
coding genes for miRNAs biogenesis. They reported that miRNAs in C19MC are 
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transcribed from intron region of non-protein-coding genes. In addition, studies suggest 
the role of exonic region of non-protein-coding genes for miRNA production (163, 164). 
Thus, miRNA can be encoded by three genomic regions in the nucleus; 1) intronic region 
of protein-coding genes, 2) exonic miRNA region in non-protein-coding genes and or 3) 
intronic region of non-protein-coding genes.  
Table 1.3. Characteristic of miRNA, siRNA, and piRNA*)  
 miRNA siRNA piRNA 
Origin  miRNA gene (exon) 
or DNA intron 
(endogenous) 
Long double 
stranded RNA 
(endegonous and/or 
exogenous) 
Repetitive elements 
such as retrotrans-
posons, DNA trans-
posons, and the 
Su(Stellate) locus 
Configuration  Single stranded 
RNA 
Double stranded 
RNA 
Single stranded 
RNA 
Length  19-25 nucleotides 21-22 nucleotides 21-33 nucleotides 
Complementarity to 
target mRNA 
Not exact  100% perfect match  100% perfect 
match 
Action  Cleveage of mRNA 
and/or translation 
inhibition  
Cleavage of mRNA  Cleavage of mRNA 
and recruitment of 
DNA methylation 
*)Adapted from (155, 165-168).  
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Biogenesis of miRNAs start with the translation of genomic region of miRNA in 
the nucleus. There are two enzymes: RNA polymerase II or RNA polymerase III, which 
mediate the transcription of miRNA (161, 169). The resulting product are called primary 
precursor of miRNA (pri-miRNA) that comprised by more than 1 kbp nucleotides with a 
double stranded stem of ~33 bp, a terminal loop and two flanking unstructured single-
stranded segments (160, 170). The pri-miRNA is cleaved by microprocessor complex 
(nuclear RNAse III Drosha/Pasha and DGCR8) to release ~65 bp hairpin-shaped 
nucleotides called precursor miRNA (pre-miRNA) (171-174). The resulting pre-miRNA 
will be exported outside the nucleus using exportin-5, which require the Ran-GTP 
cofactor (175, 176). In addition, the binding of pre-miRNA with exportin-5 also protects 
pre-miRNA from degradation (177).    
In the cytosol, pre-miRNA will subsequently cleave by another RNAse III 
nuclease called dicer to produce mature, 22 nucleotides miRNAs (178, 179). Dicer will 
recognize and bind to pre-miRNA in the 2-nt 3`-overhang in pre-miRNA through the 
PAZ domain in dicer (180-182). The binding of pre-miRNA with dicer will create a 
complex termed miRNA duplex, which will release a single stranded, mature miRNA. 
The mature miRNA will form a complex with Argonaute (Ago) protein while the other 
miRNA duplex will be degraded (170).  
Argonaute protein and its homolog are ~100 kDa proteins, which contain both 
PIWI and PAZ domain (183, 184). When the mature miRNA, as well siRNA, forms a 
complex with the argonaute, the resulting complex is referred to RNA-induced silencing 
complex (RISC) (185). The complex will identify the mRNA target based on the 
complementary bases (perfect or nearly perfect) and cleaves the mRNA at a site near the 
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middle of miRNA/siRNA complementarity (186, 187). In addition, it was proposed that 
the argonaute-bound miRNA complex could repress the translation of mRNA (188, 189). 
The mechanism in which miRNA-argonaute protein complex inhibits protein translation 
lies in the sequence motive in argonaute protein that can bind with functional 7-methyl-
guanine (m7G) cap of mRNA (190). Once the argonaute form a complex with m7G cap of 
mRNA, this cap is not accessible for elf4E to initiate the translation process of mRNA, 
resulting in translation inhibition of mRNA (191, 192).  
The translation inhibition mechanism of argonaute-miRNA complex is also 
postulated due to the ability in the formation of “pseudo-polysomes”, large EDTA 
sensitive mRNA-protein (mRNP) assemblies (193). It is hypothesized that formation of 
pseudo-polysomes was caused by protein interaction between GW182 with argonaute 
protein, which causing recruitment of 80S ribosomes to mRNA (194-196). This 
polysomes lack of translation machinery and reported to initiate mRNA degradation (197, 
198). Biogenesis, maturation and molecular mechanism of miRNA are reviewed in 
Figure 1.2.  
 
MicroRNA in Health and Disease  
Due to the important role of miRNAs in regulating gene expression in the cells, 
miRNAs have been associated with health or disease progression. For instance, miR-29b 
has been reported for bone remodeling through its effect in genes regulation in osteoclast 
and osteoblast differentiation (199, 200) while miR-200 subfamily (miR-200b/200c/429) 
has been reported to inhibit cancer metastasis in hepatocellular carcinoma (201-203). 
Thus, alteration in miRNAs level may impact health and disease progression of the host 
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and can potentially be used as diagnostic tools in various disease state such as carcinoma 
(204, 205), osteoporosis (206), type 2 diabetes mellitus and obesity (207), as well in 
cardiovascular disease (208).      
Although miRNAs are considered endogenous; e.g., miRNAs synthesized by the 
cells will be used by the cells to regulate the gene expression inside the cells, recent 
studies suggest that dietary miRNAs may contribute to the miRNAs body pool. Indeed, 
miRNAs present in food can be transferred into human through dietary means. The first 
study regarding the importance of dietary miRNAs in body pool miRNAs and the effect 
in human health was demonstrated by Zhang et al (210). In this study, they reported that 
rice miRNA, osa-miR-168a, is detected in the mouse and human sera and inhibits mRNA 
expression of LDL-receptor, thereby reducing LDL removal from the blood. However 
this study was challenged by several findings regarding the low bioavailability of plant 
miRNA in the blood (211-213). Interestingly, miRNAs present in milk and egg have been 
reported to be absorbed in biologically meaningful amount and affect human gene 
expression both in vivo and in vitro (67, 144). The discrepancies of the result was 
probably caused by the encapsulation of miRNAs in EVs that protect miRNAs from 
enzymatic degradation and harsh environment as well for miRNAs transportation across 
species (142, 214, 215).                   
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Figure 1.2. Biogenesis, maturation and molecular mechanism of miRNA. In the nucleus, 
miRNA is transcribed using RNA polymerase II/III to produce pri-miRNA. The pri-
miRNA will subsequently cleave by Drosha/Pasha to produce pre-miRNA and exported to 
cytoplasm using exportin/RAN-GTPAse. In the cytosol, pre-miRNA will be cleaved by 
Dicer, releasing mature, single stranded miRNA. Mature miRNA will form a complex with 
argonaute protein calling RNA induced-silencing complex (RISC). Several mechanisms 
and possible pathways have been proposed, e.g., inhibition of translation or mRNA 
degradation. Adapted from (209).        
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ABSTRACT 
MicroRNAs (miRNAs) can be synthesized endogenously and cause gene repression. 
Encapsulation of miRNAs in exosomes confers protection against degradation and a 
vehicle for shuttling between cells and tissues, and cellular uptake by endocytosis. 
Exosomes can be found in biological fluids and foods including milk. Evidence suggests 
that humans absorb cow’s milk exosomes and deliver the microRNA cargo to peripheral 
tissues, consistent with gene regulation by nucleic acids across species boundaries. There 
is strong evidence that milk exosomes may cross the mucosa without re-packaging in 
mice. Here, we tested the hypothesis that human vascular endothelial cells transport milk 
exosomes by endocytosis, as a crucial step toward delivery of dietary microRNAs to 
peripheral tissues. Studies were conducted using human umbilical vein endothelial cells 
and fluorophore-labeled exosomes isolated from cow’s milk. Exosome uptake followed 
Michaelis-Menten kinetics (Vmax = 0.057±0.004 ng exosome protein x 40,000 cells
-1 x 
hour-1; Km= 17.97±3.84 µg protein/200 µl media) and decreased by 80% when the 
incubation temperature was lowered from 37°C to 4°C, consistent with carrier-mediated 
transport. When exosome surface proteins were removed by treatment with proteinase K 
or transport measured in the presence of carbohydrate competitors, transport rates 
decreased by 30% to 50% compared with controls, consistent with a role of surface 
glycoproteins in endothelial transport. Treatment with cytochalasin D caused a 50% 
decrease in transport, consistent with endocytosis. We conclude that human endothelial 
cells transport bovine exosomes by endocytosis and propose that this is an important step 
in the delivery of exosome cargo to peripheral tissues. 
Keyword: endocytosis; endothelial cell; extracellular vesicles; milk exosomes; uptake  
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INTRODUCTION 
MicroRNAs (miRNAs) are small non coding RNA, which are encoded by their own 
genes, or introns and exons of long nonprotein-coding transcripts (1-3); miRNAs may 
silence genes via destabilizing of messenger RNA or preventing translation of mRNA (4, 
5). The online database miRBase, release 21, lists 1881 “high confidence” human 
miRNAs (6, 7), and about 60% of the miR-binding sites in the human genome are 
evolutionary conserved (8). Gene regulations by miRNAs has been implicated in 
numerous physiological (9) and pathological (10) conditions in humans. 
Until recently, miRNAs have been considered endogenous regulators of genes, 
i.e., miRNAs synthesized in a given organism regulate the expression of genes in that 
host. In a recent publication we have refuted this paradigm and provided strong evidence 
that 1) humans absorb biologically meaningful amounts of miRNAs from nutritionally 
relevant doses of cow's milk, 2) milk miRNAs are delivered to peripheral human tissues, 
3) physiological concentrations of milk miRNAs affect human gene expression in vivo 
and in cell cultures, and 4) endogenous synthesis of miRNAs does not compensate for 
dietary miRNAs deficiency in mice (11). That paper was the first report suggesting that 
miRNAs can be transferred between distinct animal species through dietary means. Our 
discoveries were corroborated in a recent report by investigators from the NIH-supported 
Genboree database who detected numerous dietary miRNAs in 6.8 billion sequencing 
reads from 528 human samples (12). Note that mammalian miRNAs are encapsulated in 
extracellular vesicles such as exosomes, thereby confer protection against degradation 
(13-16) and a pathway for cellular uptake by endocytosis (17, 18). Studies by us and an 
independent laboratory suggest that human and rat intestinal cells transport cow's milk 
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exosomes by endocytosis (Wolf, 2015, unpublished materials) and that milk exosomes 
may cross the intestinal mucosa without re-packaging in mice and enter circulation in 
intact form (19).  
 Here we tested the hypothesis that human endothelial cells transport cow's milk 
exosomes by a carrier-mediated process similar to the mechanism reported for the uptake 
of exosomes in intestinal cells. The uptake of dietary exosomes into endothelial cells is 
an important step in regulation of genes in peripheral tissues by dietary miRNAs in 
humans.  
 
Materials and methods  
Exosomes isolation and characterization  
Cow's milk (1% fat) was obtained from a local grocery store in Lincoln, 
Nebraska. Milk was centrifuged at 12,000 x g at 4°C for 30 minutes to remove somatic 
cells and debris. Fat-free supernatant was mixed with an equal volume of 0.25 M EDTA 
(pH 7.0) and incubated on ice for 15 minutes to precipitate casein (20). The suspension 
was ultracentrifuged at 80,000 x g at 4°C for 60 minutes (Sorvall WX Ultra 80, F37L-
8x100 rotor; Thermo Scientific, USA) to remove precipitated protein, milk fat globules, 
and microvesicles larger than exosomes. Exosomes were precipitated by centrifugation at 
120,000 x g at 4°C for 90 minutes. The exosome pellet was re-suspended in sterile 
phosphate-buffered saline and filtered through a 0.22-µm membrane filter (Milex). 
Sodium azide was added to produce a final concentration of 0.01% and exosomes were 
stored at 4°C for up to 5 days.  
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Exosome purity and absence of aggregation was assessed as recommended by the 
International Society for Extracellular Vesicles (21). Briefly, whole protein extract from 
exosomes were resolved by gel electrophoresis (10 µg protein/lane) as described 
previously (22) and membranes were probed using mouse anti-bovine CD63 (AbD 
Serotec, UK) as a marker for exosomes, rabbit anti-serum to bovine alpha s1-casein as a 
marker for the species of exosome origin, and goat anti-bovine histone H3(Santa Cruz 
Biotechnology, USA) as a negative control (all at 1,000-fold dilutions). Bands were 
visualized using an Odyssey infrared imaging system (Licor, Inc.) and IRDye 800CW-
labeled secondary antibodies (50,000-fold dilution). Anti-bovine alpha s1-casein was 
raised in rabbits (Cocalico, Inc, USA) using AHSMKEGIHAQQKEPMIGVGC coupled 
to keyhole limpet hemocyanin through amidated C-terminal and acetylated N-terminus as 
described previously (23). The anti-serum, but not pre-immunization serum, produced 
bands of the expected size with cow’s milk and the synthetic peptide antigen, but did not 
react with human breast milk (Online Supplementary Fig. 1).  Absence of exosome 
aggregation in our preparations was confirmed using negative staining transmission 
electron microscopy (Hitachi H7500, Japan) in the Microscopy Core Facility in the 
University of Nebraska-Lincoln. ImageJ (http://imagej.nih.gov/ij/index.html) was used to 
analyze the particle size of exosomes.  
Fluorophore conjugation  
Exosomes were labeled with FM-464 (Molecular Probes) as described previously 
(24). Unbound fluorophore was removed by pelleting the exosomes at 120,000 x g for 90 
minutes, followed by three wash and ultracentrifugation cycles with sterile phosphate-
buffered saline. The concentration of exosome protein was measured using a Nanodrop-
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1000 spectrophotometer (NanoDrop Technologies, Inc., USA) and diluted into F-12K 
media at the desired protein concentration.  
Cell culture  
Human umbilical vein endothelial cells (HUVEC, passages 38-45) were 
purchased from American Type Culture Collection (CRL-1730) and cultured in F-12K 
medium, supplemented with 0.04 mg/ml endothelial cell growth supplement (Sigma), 0.1 
mg/ml heparin (Sigma), 10,000 units of penicillin, 10 mg of streptomycin and 10% 
exosomes-free fetal bovine serum in a humidified atmosphere at 5% CO2 and 37° C. 
Exosome-free fetal bovine serum was prepared by sonicating the serum in a water bath 
for 1 hour, which destroyed most of the marker miRNA present in FBS (Online 
Supplementary Fig. 2). Media was replaced with fresh media every 48 hours.  
Transport studies  
In a typical experiment, 15x103 HUVECs were seeded per well in a 96-well plate 
and allowed to adhere overnight. . Fluorophore-labeled exosomes were added to the wells 
to produce the desired concentration of exosome protein. Cells were incubated for the 
length of time denoted in Results. Media were removed and cells were washed three 
times with sterile PBS to remove extracellular exosomes. Controls were prepared by 
washing the cells immediately after addition of exosomes. Cell fluorescence (560/645 
nm) was measured in a microplate spectrophotometer (BioTek, USA). Cells were 
harvested using trypsin and counted using a hemocytometer. Units of fluorescence were 
converted into mass of exosome transported by labeling a known mass of exosomes 
(protein) with fluorophore, and quantifying the fluorescence after removing unbound 
fluorophore. In select experiments, we measured the effects of the following treatments 
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on exosome transport: 1) cells were treated with 5 or 10 µg/mL of endocytosis inhibitor 
cytochalasin D (Gibco) for 30 minutes before adding exosomes (25); 2) cells were treated 
with 150 mM carbohydrate competitors D-glucose or D-galactose for 30 minutes before 
adding exosomes (26); and exosomes were treated with 100 µg/mL of proteinase K at 
37°C for 30 minutes to remove surface proteins (18). All assays were performed in 
triplicate in at least three independent experiments. Transport kinetics were modeled 
using the Michaelis-Menten equation and non-linear regression; modeling was conducted 
using GraphPad Prism 6.0 (GraphPad Software, La Jolla, CA, USA).  
Statistical Analysis  
Means±standard deviations are reported. Homogeneity of variances among 
groups confirmed using Bartlett’s test (27, 28). Statistical significance of differences 
among treatment groups was assessed using one-way ANOVA and Tukey-Kramer post 
hoc test. Analyses were performed in GraphPad Prism 6.0 (GraphPad Software, La Jolla, 
CA, USA). Differences were considered significant if p<0.05. 
 
Results  
Our exosome purification protocol yielded preparations of non-aggregated 
extracellular vesicles that were primarily composed of exosomes. When protein extracts 
were probed with anti-CD63 or anti-bovine alpha s1-casein strong bands were observed 
in western blots; in contrast, when protein extracts were probed with anti-histone H3 
(negative control) no band was visible (Fig. 1A). The particle suspension was largely free 
of aggregates and the shape and contour of exosomes suggested vesicle integrity (Fig. 
1B) with the particle size of 69±19.5 in diameter as expected for exosomes (29).   
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The uptake of milk exosomes into HUVECs is a carrier-mediated process. First, 
we established that exosomes uptake was linear with time up to one hour if 70 µg 
exosome protein was added to 200 µL media (Figure 2A), i.e. concentration below 
transporter saturation (see below). Subsequent transport studies were carried out using an 
incubation time of one hour. Exosome uptake followed Michaelis-Menten kinetics 
(Figure 2B): Vmax=0.057±0.004 ng exosome protein x 40,000 cells
-1 x hour-1 and Km= 
18.0±3.84 µg exosome protein/200 µL media. Exosomes uptake depended on the 
incubation temperature (Fig. 3). When a 5-fold excess (equaling to 6 times Km) of 
unlabeled exosomes as added to the cell cultures, the uptake of fluorophore-conjugated 
exosomes decreased to 16.83±0.07 % of control (P<0.05, n=3 biological replicates each 
measured in triplicates). When cells were treated with 5 or 10 µg/ml, exosome uptake 
decreased to 63.5±21.3% and 40.8±22.0%, respectively, of controls, consistent with 
endocytosis. 
Surface proteins played an important role in facilitating exosome uptake into 
HUVECs. When exosomal surface proteins were removed by treatment with proteinase 
K, exosome uptake decreased to about 50% of controls (Fig. 4A). The carbohydrate 
competitor galactose, but not glucose, caused a significant decrease in exosome uptake 
(Fig. 4B).     
 
Discussion  
Evidence is accumulating in support of the theory that dietary miRNAs may cross 
the intestinal mucosa and has biological activity in humans (11, 12, 19, 30). However, the 
mechanisms of intestinal transport and subsequent delivery to tissues are unknown. To 
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the best of our knowledge, this is the first paper to propose that the transport of cow’s 
milk exosomes across vascular endothelial cells is mediated by endocytosis and that 
proteins on the surface of milk exosomes are compatible with proteins on the surface of 
human vascular endothelial cells. This study further corroborates the notion that dietary 
miRNAs have biological activity in humans. 
This study has far-reaching implications for human nutrition and health. The 
National Cancer Institute defines bioactive compounds as “a type of chemical found in 
small amounts in plants and certain foods […]. Bioactive compounds have actions in the 
body that may promote good health. They are being studied in the prevention of […] 
diseases” (31). Milk miRNAs meet that definition, based on our previous studies (11). 
Future studies will need to reveal the extent to which dietary miRNAS contribute to the 
total miRNA body pool. 
miRNAs have been implicated in virtually all aspects of human health and disease 
including bone health (32, 33), female and male reproduction (34, 35), arthritis and 
inflammatory bowel disease (36-38), metabolic syndrome (39-42), and cancer (43). Note 
that miRNAs also may have effects detrimental to human health. For example, the 
plasma concentrations of miR-210 are significantly higher in patients with pancreatic 
cancer compared with healthy controls (44), plasma miR-141 and miR-25 are elevated in 
prostate cancer and esophageal squamous cell carcinoma, respectively (45); plasma miR-
21 is elevated in various types of cancer (46); and the urinary excretion of miR-126 and 
miR-182 is greater in bladder cancer patients compared with healthy controls (47). 
Additional areas of health relevance include the possible use of milk exosomes as 
vehicle for the oral delivery of unstable drugs, and the potential role of dietary miRNAs 
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as confounders in biomarker studies that rely on miRNAs in body fluids. Evidence 
suggests that that dietary preferences affect miRNA signatures in human plasma (48). 
Some uncertainties remain and will need to be addressed in future studies. First, 
the identities of the glycoproteins that mediates endocytosis of milk exosomes in 
endothelial cells is unknown and is an area of investigation in our laboratory. Second, it 
is possible that an excess of endogenous exosomes might compete with the endocytosis 
of dietary exosomes. We cannot assess this possibility until the plasma concentration of 
dietary exosomes has been established; distinct glycoproteome profiles on the surfaces of 
cells from distinct tissues might be a confounder in such studies. Third, our studies did 
not formally exclude the remote possibility that adherence to cells, rather than uptake into 
cells, accounted for cell fluorescence. We consider the mere adhesion of exosomes to cell 
surfaces an unlikely scenario, based on previous studies suggesting that milk exosomes 
may cross the intestinal mucosa without re-packaging in mice and enter circulation in 
intact form (19). Also, our own studies of intestinal transport of milk exosomes in human 
and rat cell cultures suggest that exosomes are endocytosed at the apical membrane for 
subsequent secretion across the basolateral membrane. Fourth, it is unknown whether 
dietary exosomes from species remotely related will be recognized by surface proteins in 
human cells. 
We conclude that this study provides an important mechanistic framework for 
future studies of dietary extracellular vesicles and the roles of dietary miRNAs in human 
health and disease. In particular, due to the controversy surrounding the bioavailability of 
plant-borne miRNAs in humans, resources need to be devoted to this promising field of 
62 
 
research. A representative example would be the identification and validation of 
molecular signatures for assessing the dietary intake of vesicles and their cargo.  
 
ABBREVIATIONS USED 
miR, microRNA; miRNA, microRNA; HUVEC, human umbilical vein endotelial cells  
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FIGURE 2.1. A: western blot result showing the absence of intercellular protein histone 
H3 but positive for commonly enriched exosomal protein; CD63 and bovine protein 
origin; alpha s1-casein. B: electron microscopy images of cow’s milk exosomes showing 
round shape (69±19.5 nm) and intact vesicles.     
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FIGURE 2.2. Milk exosomes uptake is time (A) and dose (B) dependent (n=9, 3 
independent replicates).  
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FIGURE 2.3. Reducing temperature to room temperature and 4°C significantly reduced 
exosomes uptake (n=9 from 3 biological replicates; p<0.05).  
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FIGURE 2.4. Treatment of exosomes with proteinase K (Prot K) and addition of 
unlabeled exosomes (Exosome) (A) as well endocytosis inhibitors (B) significantly 
reduced milk exosome uptake (n=9, 3 independent experiments, p<0.05).    
  
 
 
  
 
 
  
 
 
 
0 
20 
40 
60 
80 
100 
120 
140 
control Prot K EVs Exosomes 
a 
b 
c Ex
o
s
o
m
e
 u
p
ta
k
e
 (
%
 t
o
 
c
o
n
tr
o
l)
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
0 
20 
40 
60 
80 
100 
120 
control 5 mg/mL 10 mg/mL D-glucose D-galactose 
a 
b 
b 
ab 
b 
E
x
o
s
o
m
e
 u
p
ta
k
e
 (
%
 t
o
 
c
o
n
tr
o
l)
 
Cytochalasin D 
A) 
B) 
74 
 
 
 
 
 
 
 
Chapter 3 
Loss of miRNAs during Processing and 
Storage of Cows (Bos taurus) Milk 
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ABSTRACT 
MicroRNAs (miRs, miRNAs) play central roles in gene regulation. Previously, we 
reported that miRNAs from pasteurized, store-bought bovine milk have biological 
activity in humans. Here we assessed the effects of milk processing, storage, somatic cell 
content, and handling by consumers on the degradation of miRNAs in milk; we also 
quantified miRNAs in dairy products. Pasteurization and homogenization caused a 63% 
loss of miR-200c, whereas a 67% loss observed for miR-29b was statistically significant 
only in skim milk. Effects of cold storage and somatic cell content were quantitatively 
minor (<2% loss). Heating in the microwave caused a 40% loss of miR-29b but no loss of 
miR-200c. Milk fat content had no effect on miRNA stability during storage and 
microwave heating. The concentrations of miRNAs in dairy products were considerably 
lower than in store-bought milk. We conclude that processing of milk by dairies and 
handling by consumers causes a significant loss of miRNAs. 
 
Key words: heating, MiRNAs, milk, processing, storage 
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INTRODUCTION 
MicroRNAs (miRs, miRNAs) are small non-coding RNAs that play essential roles in the 
regulation of genes at the posttranscriptional level in plants and animals.1 Mature 
miRNAs are about 22 nucleotides long and bind to complementary sequences in the 3’-
untranslated region of mRNAs. Perfect or near perfect base pairing of the miRNAs and 
its target mRNAs typically results in mRNAs degradation, whereas less perfect base 
pairing typically results in inhibition of mRNAs translation.2-3 Traditionally, miRNAs 
have been considered endogenous regulators of genes, i.e., miRNAs synthesized by a 
given host regulate the expression of genes in that host. Recently, our laboratory refuted 
this paradigm. We provided strong evidence that 1) humans absorb biologically 
meaningful amounts of miRNAs from nutritionally relevant doses of cow’s milk, 2) 
physiological concentrations of milk miRNAs affect human gene expression in vivo and 
in cell cultures, and 3) endogenous synthesis of miRNAs does not compensate for dietary 
miRNA deficiency in mice.4 Our discoveries were largely modeled on miR-29b and miR-
200c, but likely hold true for all miRNAs encapsulated in milk exosomes.5-6 To the best 
of our knowledge, our previous paper is the first to provide unambiguous evidence that 
miRNAs can be transferred between distinct species through dietary means. In contrast, 
previous claims that miRNAs from plants affect human gene expression7-8 are highly 
controversial and were met with skepticism by the scientific community.4, 9-12 Based on 
the above observations, milk miRNAs are a novel class of bioactive food compounds as 
defined by the National Cancer Institute in the United States.13 The discovery that milk 
miRNAs are bioactive food compounds has broader implications as miRNAs play 
essential roles in gene regulation,2-3 cell communication,14-15 and human health.16-23 
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This study focused on determining the effect of milk processing, storage, somatic 
cell content, and handling by consumers on two miRNAs, miR-29b and miR-200c levels 
based on the following rationale. In bovine milk, miR-29b and miR-200c are among the 
most abundant miRNAs.20 MiR-29b is an important regulator of bone mineralization in 
humans, as it increases osteoblast differentiation16 and decreases osteoclast differentiation 
and function.17 MiR-200c decreases cancer risk by targeting the transcription factor 
ZEB1, which induces E-cadherin expression, thereby limiting epithelial-to-mesenchymal 
transition, a key event in metastasis.24-25 Also, the nucleotide sequences of miR-29b and 
miR-200c in bovine milk are identical to those of their human orthologs.26 Our rationale 
for including the somatic cell count in our analysis was to assess whether an increase in 
milk cells, as seen in mastitis, might be a confounder in the analysis of milk miRNAs. 
In Western societies, the majority of milk is processed prior to consumption. In fact, 
the production and sale of raw milk dairy products is illegal in many states in the United 
States and pasteurization is required.27 Moreover, while the per capita consumption of 
milk has declined from 236 pounds in 1982 to 195 pounds in 2012, total dairy 
consumption increased by 11% during the same time period.28 Therefore, we considered 
it worthwhile to assess the effects of processing on the miRNA content in both milk and 
dairy products. 
Little is known about the effects of processing and storage on milk miRNAs levels. 
In two studies, synthetic miRNAs were added to bovine milk and their stability after 
exposure to harsh treatments such as acid and RNase was assessed and compared to the 
stability of endogenous miRNAs in milk.6, 20 Synthetic miRNAs were rapidly degraded, 
whereas endogenous miRNAs were resistant to treatment. However, the harsh treatments 
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applied in these studies are not representative of the treatments applied in commercial 
dairy production. In this study, we assessed the effects of pasteurization, fat content, cold 
storage, heating as well as processing into dairy products on content of milk miRNAs. 
 
MATERIALS AND METHODS 
Chemicals. Guanidinium thiocyanate and ethanol were purchased for use in the 
NucleoSpin miRNA plasma RNA extraction kit (Macherey-Nagel Inc., Bethlehem, PA). 
TRIzol was purchased from Life Technologies (Grand Island, NY). 
Milk and dairy products. Raw, whole, 2%, and skim cow’s (Bos taurus) milk was 
obtained from The Pennsylvania State University Creamery (University Park, PA) from 
separate collections in three consecutive weeks in May 2014.  All milk was procured 
from the Penn State Animal Science Department’s Holsteins breed herd.   The milk for 
this study was processed from using raw milk and cream routinely supplied to the Penn 
State Berkey Creamery, University Park, PA and stored under intermittent agitation in a 
22,712.5 liter raw milk silo at 2.2°C (Feldmeier Equipment, E-015-05;  Little Falls, NY).  
The milk contained 3.25% milk fat and 8.9% milk solids non-fat (near-infrared method, 
CEM, Turbo Smart5, Model 907990; Matthews, NC).  
For the preparation of the product, milk (3.25% Milk Fat; 12.15% Milk Solids Non Fat) 
was pasteurized at 75.55°C with a 28-s holding time (APV Paraflow, Serial number 
20053003000302; Goldsboro, NC).  It was homogenized at 145 Bar and 60°C (APV 
Gaulin Homogenizer, Serial Number 20052410702; Lake Mills, WI).  The product was 
standardized using a Westfalia Separator, type MSE 55-01-177; Oelde, Germany.  A 
details and process diagram for preparation of whole cow’s milk is presented in figure 1.  
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After cooling the product was transferred to a 7200 liter refrigerated storage tank at 2.2°C 
(Feldmeier Equipment, E-015-05; Little Falls, NY).  The product was bottled on filling 
machine (Federal Manufacturing, Serial Number 1/12.4GL843; Milwaukee, WI) and 
stored in a conventional cold-milk warehouse at 3.0°C.  
 On our initial collection dates, milk of all fat levels were stored at 4ºC for up to 15 days, and 
aliquots were taken and frozen at -80ºC every other day. In a separate experiment bovine cells 
were removed from raw milk by centrifugation (500 g, 10 min, 4°C) to determine 
whether somatic cells are a meaningful confounder when analyzing the concentrations of 
miRNAs in milk from healthy cows. Samples were frozen at -80°C and shipped on dry 
ice to Lincoln, NE, for miRNA analysis.  Samples from all fat levels of milk on day 15 
were heated in the microwave for 15 seconds and analyzed after cooling off to room 
temperature. Dairy products other than milk were purchased from grocery stores in 
Lincoln, NE. All samples were produced and analyzed as biological repeats in triplicate. 
MiRNA analysis. Milk samples were spiked with a synthetic internal standard (twenty-
five attomoles) prior to extraction of miRNAs using miSPIKE Synthetic RNA (IDT 
Technologies).4 Dairy products (100 mg) other than milk were extracted using TRIzol 
prior to addition of the synthetic internal standard. MiR-29b and miR-200c were 
quantified using quantitative real-time PCR as described previously.4 
Statistics. Analysis by Bartlett’s Test Homogeneity suggested that variances were 
homogeneous.29 The paired t-test was used for pairwise comparisons. One-way analysis 
of variance (ANOVA) and Fisher’s protected least significant differences were used 
when comparing more than two groups. Repeated measures ANOVA was used for 
assessing the effects of storage time on miRNA concentration. StatView 5.0.1 (SAS 
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Institute; Cary, NC) was used for conducting statistical analyses. Means ± SD are 
reported. Differences were considered statistically significant if P≤ 0.05. 
 
RESULTS 
Pasteurization and homogenization of raw milk resulted in a 63±28% decrease of 
miR-200c in whole milk; effects were similar for 2% fat milk and skim milk (Fig. 3.1A). 
The effect was less pronounced for miR-29b for which a significant decrease (67±18%) 
was observed only in skim milk (Fig. 3.1B).  Cold storage of milk did not affect the 
concentration of mir-29b and miR-200c in whole milk, 2% milk and skim milk up to 15 
days; 2% fat milk is shown as a representative example in Fig. 3.2.  Somatic cells are not 
meaningful confounds regarding the analysis of miRNAs in milk from healthy cows. 
When somatic cells were removed from raw milk by centrifugation and analyzed for 
miRNA content, the cellular miRNAs were found to contribute less than 2% of the total 
miRNAs present in raw milk before centrifugation: 1.1±0.9% for miR-29b and 
0.14±0.08% for miR-200c. 
Processing in the household has the potential to cause a considerable loss of some 
miRNAs in milk. For example, the concentration of miR-29b decreased by 40±28% when 
processed milk was heated in the microwave and cooled to room temperature compared 
to milk before heating (Fig. 3.3).  In contrast, when milk was heated in the microwave the 
concentration of miR-200c was not statistically different compared with unheated 
controls.   
The concentration of miRNAs varied considerably among the product tested (Table 
3.1), but were generally lower than the concentration in pasteurized whole milk (compare 
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to figure 3.2). Fresco queso dip was a notable exception and contained higher 
concentrations of miRNAs than those observed in milk.  
 
DISCUSSION 
In a recent paper we reported the importance of milk miRNAs for gene regulation in 
humans.4 That report has major implications for the roles of milk and possibly other dairy 
products in human health. Cow’s milk contains meaningful quantities of 245 miRNAs,20, 
30 and 71.4% of these miRNAs are predicted to target about 11,000 human transcripts 
(unpublished observations). In addition to the roles of miR-29b and miR-200c in bone 
health and cancer prevention,16-17, 24-25 respectively, miRNAs have been implicated in 
various aspects of human health and disease including hypertension, insulin resistance 
and diabetes, hyperlipidemia and atherosclerosis, reproduction, immune function and 
Crohn’s disease.18, 20-21, 31-33 
We propose that milk has a meaningful effect on human health, mediated by 
miRNA-dependent gene regulation. The potential importance of dietary milk miRNA 
intake is supported by data suggesting that 1) Americans consume large quantities of 
milk and dairy products,28 2) a large proportion of milk miRNAs is encapsulated in 
extracellular vesicles, thereby providing protection against degradation 5-6 and a pathway 
for cellular uptake by endocytosis,34-35, and 3) milk miRNAs are  resistant against 
degradation during storage (this study). 
The concentrations of miRNAs varied considerably among the dairy products tested 
(Table 1), but were generally lower than the concentrations in pasteurized whole milk 
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(compare Fig. 2). Fresco Queso Dip was a notable exception and contained higher 
concentrations of miRNAs than those observed in milk. 
Our previous studies of milk miRNAs in humans and mice were conducted using 1% 
fat milk from the grocery store.4 Based on this study, the content of miRNAs is about two 
times higher in unprocessed milk compared with pasteurized, store-bought milk. Note 
that we have no intent recommending the consumption of raw cow’s milk by humans, 
because of food safety concerns associated with raw milk. We observed that a loss of 
milk miRNAs occurred only during pasteurization, homogenization, and processing to 
dairy products. This observation is consistent with previous studies of milk miRNAs. For 
example, endogenous miRNAs were not degraded when milk was exposed to harsh 
treatments such as low pH or treatment with RNase.6, 20 It is reasonable to propose that 
encapsulation of miRNAs in extracellular vesicles5 prevents miRNA degradation, based 
on the following lines of evidence. 1) When synthetic miRNAs are added to milk and 
subjected to low pH or RNase treatment, the miRNAs are rapidly degraded.6, 20 2) When 
exosome membranes in milk were disrupted by sonication for preparing miRNA-depleted 
mouse diets in previous studies, miR-29b was rapidly degraded to concentrations below 
detection limit.4 Presumably, degradation was due to milk RNases gaining access to 
miRNAs released from exosomes. 3) When milk was fermented to produce yoghurt, 
miRNA concentrations decreased to levels much lower than in milk (this study). We 
speculate that the decrease was due to the lysis of exosomes during fermentation and the 
large amounts of RNases produced by microbes. 4) When milk was homogenized, 
miRNA concentrations decreased by on average 50% (this study). We speculate that the 
decrease was caused by a disruption of exosome mebranes by shear forces applied during 
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homogenization. Collectively, our studies suggest that milk, and perhaps dairy products, 
have the potential to contribute to the miRNA body pool in humans. 
Some uncertainties remain to be addressed in future studies. For example, this study 
was modeled based on miR-29b and miR-200c, however, there is a possibility that 
distinct miRNAs may be differentially metabolized.8, 36 Another layer of uncertainty is 
the possible effects of feeding regimens, season, and breed on the miRNA content in 
milk. Moreover, while this study suggests that somatic cells in milk from healthy cows do 
not contribute meaningful amounts to the total miRNA content in milk, it is possible that 
the increased somatic cell count in milk from cows suffering from mastitis37 may cause 
an artificial increase in milk miRNA concentrations. Our previous studies suggest that 
plasma miRNA concentrations decrease by 61% in mice fed a milk miRNA-depleted diet 
for four weeks. This observation is consistent with milk miRNAs contributing 
meaningful quantities to the miRNA body pool, but does not necessarily establish the 
essentiality of dietary miRNA intake. Clearly, this is an uncertainty that will need to be 
addressed in future studies. Finally, it is conceivable that miRNAs from foods other than 
milk also contribute toward the total body pool of miRNAs. 
ABBREVIATIONS USED 
miR, microRNA; miRNA, microRNA 
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Figure 3.1. Loss of miR-200c (A) and miR-29b (B) during milk pasteurization and 
homogenization of milk with different fat content. a,bSignificantly different (n=3 
biological replicates, P<0.05). 
 
 
 
 
  
0 
10 
20 
30 
40 
50 
60 
Raw Whole  2% Skim 
m
iR
-2
9
b
 (
fm
o
l/
L
) 
B) a 
ab 
ab 
b 
0 
500 
1000 
1500 
2000 
2500 
Raw Whole 2% Skim 
m
iR
-2
0
0
c
 (
fm
o
l/
L
) 
A) 
b 
a 
b 
b 
Pasteurization & 
Homogenization 
Pasteurization & 
Homogenization 
92 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2: Storage at 4°C did not affect the concentrations of miR-29b in pasteurized 
and homogenized 2% fat milk (n=3 biological replicates, P>0.05). 
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Figure 3.3: Loss of miR-29b (A) and miR-200c (B) during heating of whole milk in the 
microwave after 15 days of storage at 4°C. Abbreviation: MW, microwaved. 
a,bSignificantly different (n=3 biological replicates, P<0.05). 
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Table 3.1. Concentration of miRNAs-29b and -200c in dairy products 
 MiRNA 
  _______________   ______________  
Product miR-29b miR-
200c 
 fmol/kg 
Best Choice Yogurt 0.9±0.10 37.6±2.8 
Fresco Queso Dip  36.1±5.5  1029.8±478.6 
Greek Yogurt  14.2±3.9  462.3±126.9 
Half and Half 3.0±0.17 513.3±159.2 
Heavy Whip Cream 2.6±1.3 342.0±132.9 
Parmesan Cheese                     4.9±1.9                              
232.0±64.5 
Upstate Farm Yogurt  2.4±1.0 216.9±93.8 
Data are means±SD, n=3. 
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Chapter 4  
Future Study 
96 
 
Although there is still a debate whether miRNA can be transferred across species 
(1-3), our lab has provided an evidence that miRNA indeed can be transported across 
species (4, 5). It is hypothesized that the miRNA transport across species was mediated 
by exosomes or other extracellular vesicles as these small vesicles protect the miRNA 
from enzymatic degradation and harsh environment such as low pH (6, 7). Furthermore, 
exosomes also facilitated the transport into the recipient cells as numerous studies have 
reported the ability of the cells to internalize exosomes and use the miRNA cargo inside 
exosomes to promote function (5, 8-12).  
In recent study, we provide another evidence that cow’s milk exosomes can be 
transported into human endothelial cells through endocytosis process. However, several 
endocytosis pathway warrant further study. For instance, we only provide the evidence 
that the transport was mediated by actin-dependent process. Actin is required for most 
endocytosis process including phagocytosis, macropinocytosis and chlatrin-mediated 
endocytosis (13-15). This indicated the non-specific endocytosis mechanism that 
mediated the uptake of cow’s milk exosomes into human endothelial cells. Therefore, it 
is necessary to address this issue by performing another inhibitory studies or protein 
inhibition through RNA interference, specific for each endocytosis mechanism, to answer 
specific endocytosis-mechanism.  
Study suggest that surface glycoprotein in exosomes play an important role in 
cellular recognition and internalization of exosomes by target cells (16-18). In this study 
we suggest that glycoprotein surface in cow’s milk exosomes is important for mediating 
the uptake into human endothelial cells as indicated by lower uptake of cow’s milk 
exosomes in the presence of galactose and when the milk exosomes was treated with 
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proteinase K. It is interesting if we could provide the glycoprotein class or component in 
surface area of cow’s milk exosomes that mediated the uptake process in human 
endothelial cells. Thus, performing another transport study using surface-blunt 
glycoprotein of milk exosome is important in the future to characterize the glycoproteins 
that mediates the uptake in human cell. Additional mass-spectrophotometry (MS) to 
identify the surface glycoprotein in cow’s milk exosome can also be used to support the 
data derived from the transport study using surface-blunt glycoprotein of cow’s milk 
exosomes.      
In addition, we only based our experiment by indirect observations. It is still not 
clear whether the exosomes from cow’s milk is indeed internalized by endocytosis, not 
by fusion with plasma membrane. Electron microscopy image or phase contrast 
microscopy should be performed in the future study to clarify the data obtained by the 
FM4-64 labelled exosomes.  
Recent study suggests that cow’s milk exosome can be transported across the rat’s 
intestinal cells without being degraded or repackaged by the intestinal cells (19). 
However, question remains whether this event occur in human peripheral cells and the 
miRNAs present in cow’s milk exosomes can promote function after being transported 
across endothelial cells. Transwell study is a way to answer this question. In the first 
experiment, HUVEC were grown in the apical surface and cow’s milk exosomes were 
added when HUVECs have formed monolayer in the apical surface. Exosomes was 
isolated from the apical and basolateral surfaces of transwell by using differential 
centrifugation method. Electron microscopy, western blot and Q-RT-PCR for selected 
miRNAs were performed to characterize the exosomes isolated from both of the surfaces. 
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In the second experiment, HUVECs were grown in the apical surface of transwell and 
stable transfected HEK-293 carrying the miR-200c reporting gene were grown in the 
basolateral of transwell. Milk exosomes was added and luciferase activity was measured 
after incubation for several hours.  
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qRT-PCR primers used to quantify gene expression 
 
microRNA Forward Primer Sequence (5-3’) Reverse Primer Sequence (3-5’) 
miSpike CTCAGGATGGCGGAGCGGTCT  Universal primer mix 
miR-29b GTAGCACCATTTGAATCAGTGTT Universal primer mix 
miR-200c TAATACTGCCGGGTAATGATGGA Universal primer mix 
 
